JPS5238017A - Immunological medicine being active in aqueous solution - Google Patents

Immunological medicine being active in aqueous solution

Info

Publication number
JPS5238017A
JPS5238017A JP51101751A JP10175176A JPS5238017A JP S5238017 A JPS5238017 A JP S5238017A JP 51101751 A JP51101751 A JP 51101751A JP 10175176 A JP10175176 A JP 10175176A JP S5238017 A JPS5238017 A JP S5238017A
Authority
JP
Japan
Prior art keywords
active
aqueous solution
immunological
medicine
immunological medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51101751A
Other languages
English (en)
Japanese (ja)
Inventor
Shiedeidou Rui
Odeipeeru Furansowaazu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of JPS5238017A publication Critical patent/JPS5238017A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/355—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Nocardia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP51101751A 1975-08-29 1976-08-27 Immunological medicine being active in aqueous solution Pending JPS5238017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7526704A FR2321896A1 (fr) 1975-08-29 1975-08-29 Agents adjuvants immunologiques actifs en solution aqueuse

Publications (1)

Publication Number Publication Date
JPS5238017A true JPS5238017A (en) 1977-03-24

Family

ID=9159489

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51101751A Pending JPS5238017A (en) 1975-08-29 1976-08-27 Immunological medicine being active in aqueous solution

Country Status (7)

Country Link
US (1) US4094971A (en, 2012)
JP (1) JPS5238017A (en, 2012)
BE (1) BE845557A (en, 2012)
DE (1) DE2638762A1 (en, 2012)
FR (1) FR2321896A1 (en, 2012)
GB (1) GB1557712A (en, 2012)
NL (1) NL7609541A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63316726A (ja) * 1987-06-18 1988-12-26 Kureha Chem Ind Co Ltd 抗レトロウィルス剤

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
US4313934A (en) * 1979-05-08 1982-02-02 Kirin Beer Kabushiki Kaisha Physiologically active polysaccharides, production and uses thereof
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
SE8601563D0 (sv) * 1986-04-08 1986-04-08 Carbomatrix Ab Matrismaterial, forfarande for framstellning derav och anvendning derav
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
DE4231675C2 (de) * 1992-09-22 1994-07-14 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie
EP0702563B1 (en) * 1993-05-27 2003-08-06 EntreMed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders
US5562909A (en) * 1993-07-12 1996-10-08 Massachusetts Institute Of Technology Phosphazene polyelectrolytes as immunoadjuvants
US5773011A (en) * 1993-09-27 1998-06-30 Gerbu Biotechnik Gmbh Method of preparing a synergistic immunological adjuvant formulation
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
US6083513A (en) * 1993-11-16 2000-07-04 Gerbu Biotechnik Gmbh Method for increasing the yield of antibodies in the techniques of immunology
US5882520A (en) * 1995-10-26 1999-03-16 The University Of Montana Use of arabinogalactan in aqueous two phase extractions
US20060134141A1 (en) * 2004-12-14 2006-06-22 Nabi Biopharmaceuticals Glycoconjugate vaccines containing peptidoglycan
EP1898948B1 (en) * 2005-06-08 2012-01-04 Yisheng Biopharma (Singapore) Pte. Ltd. Polyinosinic acid-polycytidylic acid-based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
WO2012070974A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Вакцины с повышенной иммуногенностью и способы их получения
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (en, 2012) * 1971-11-19 1975-02-07 Anvar
NL7308450A (en, 2012) * 1972-06-20 1973-12-27
FR2268531B1 (en, 2012) * 1974-04-25 1978-07-21 Anvar
FR2269962B1 (en, 2012) * 1974-05-06 1978-02-03 Anvar
FR2269961B1 (en, 2012) * 1974-05-06 1978-03-24 Anvar

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63316726A (ja) * 1987-06-18 1988-12-26 Kureha Chem Ind Co Ltd 抗レトロウィルス剤

Also Published As

Publication number Publication date
BE845557A (fr) 1977-02-28
DE2638762A1 (de) 1977-03-10
FR2321896A1 (fr) 1977-03-25
FR2321896B1 (en, 2012) 1978-08-11
NL7609541A (nl) 1977-03-02
US4094971A (en) 1978-06-13
GB1557712A (en) 1979-12-12

Similar Documents

Publication Publication Date Title
JPS5238017A (en) Immunological medicine being active in aqueous solution
HK86679A (en) Dethiacephalosporanic acid derivatives and their preparation and use
JPS51116096A (en) Blood processor
ZA767340B (en) Improvements in medicaments
JPS5239997A (en) Blood processor
JPS5244228A (en) Antigenic medicine
JPS5273805A (en) Stable alminium alkokyside solusion and its preparation
IL50657A (en) 11-deoxy-16-aryl- -tetranor-prosta-cis-5-ene-13-yneoic acid derivatives and their preparation
JPS52104497A (en) Particle dissolved aqueous solution
GR60264B (en) Stable solutions and processes for their preparation
JPS52148627A (en) Medicine having antiiarrhythmia active prorerty
AU1522876A (en) D1-and 8r-9-fluoro-prostadianoic acid
JPS5259984A (en) Small bottle type syringe unit
JPS529638A (en) Tinnelectroplating solution
JPS5243565A (en) Nursing bottle
GR60560B (en) Penicillines,preparation process and use thereof as medicines
AU2051676A (en) 7-acylamido-3-cephem-4-carboxylic acid
JPS5225012A (en) Stable aqueous solution disperting effective iodine in iodine mixture
EG10793A (en) Indole-carboxylic acid derivatives and the preparation thereof
JPS51128430A (en) Nonnmedical thiocemi carbazone germicide
JPS527421A (en) Eyewash
JPS523060A (en) Paraachlorophenoxyisobutyric acid derivatives and preparation thereof
IL43825A0 (en) Herbicidal preparations containing phenoxy-carboxylic acid oxime-esters
JPS52108015A (en) Low concentrated pyrokalpine eyewash solution
JPS52148615A (en) Aqueous biologically active solution